Lifevantage (NASDAQ:LFVN) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Key Points

• Lifevantage reported quarterly EPS of $0.11, missing analysts’ consensus estimate by $0.01. The company posted a 2.94% net margin and a 23.89% return on equity.
• Shares fell 2.4% to $6.45 following the results. Analysts maintain a consensus “Hold” rating with a $5.00 price target.
• Lifevantage declared a quarterly dividend of $0.05, equivalent to $0.20 annually and a 3.1% yield; institutional investors own 35.32% of the company.

Lifevantage (NASDAQ:LFVN - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01), FiscalAI reports. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%.

Lifevantage Stock Down 2.4%

Shares of LFVN stock traded down $0.16 on Thursday, reaching $6.45. The stock had a trading volume of 98,308 shares, compared to its average volume of 272,217. The firm's 50-day moving average is $6.42 and its two-hundred day moving average is $5.83. The firm has a market capitalization of $81.40 million, a price-to-earnings ratio of 14.33 and a beta of 0.72. Lifevantage has a 12 month low of $3.90 and a 12 month high of $14.28.

Lifevantage Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Tuesday, September 1st. Lifevantage's dividend payout ratio is presently 44.44%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Lake Street Capital lowered Lifevantage from a "buy" rating to a "hold" rating and set a $5.00 target price for the company. in a research note on Thursday, May 7th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Lifevantage in a research note on Friday, August 21st. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $5.00.

Hedge Funds Weigh In On Lifevantage

Several institutional investors and hedge funds have recently made changes to their positions in LFVN. Cubist Systematic Strategies LLC bought a new stake in shares of Lifevantage during the 1st quarter valued at $97,000. Jones Financial Companies Lllp lifted its stake in shares of Lifevantage by 14,484.0% in the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company's stock valued at $425,000 after acquiring an additional 28,968 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Lifevantage by 24.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company's stock worth $649,000 after buying an additional 8,762 shares during the period. Jane Street Group LLC increased its holdings in Lifevantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company's stock valued at $533,000 after purchasing an additional 1,877 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company's stock worth $3,210,000 after purchasing an additional 126,274 shares during the last quarter. Institutional investors and hedge funds own 35.32% of the company's stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source